Rex Jordi, Paradelo Cristina, Mangas Cristina, Hilari Josep Maria, Fernández-Figueras María Teresa, Ferrándiz Carlos
Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Universitat Autonoma de Barcelona, Badalona, Spain.
Dermatol Surg. 2009 Oct;35(10):1505-13. doi: 10.1111/j.1524-4725.2009.01265.x. Epub 2009 Jul 20.
Although acral lentiginous melanoma is the most common subtype of malignant melanoma in acral locations, the term acral melanoma (AM) has to be differentiated from the histopathologic description.
To characterize the clinical and pathologic features of patients with a primary AM and to elucidate whether the prognosis of patients with AM differs from that of those with melanoma at other sites (nonacral melanoma; NAM).
Over a 20-year period, a series of 822 consecutive patients with melanoma were recorded in the database. Clinical and follow-up data were retrieved from the melanoma register and prospectively analyzed.
Eighty-nine patients had a malignant melanoma located on the acral sites of extremities. Breslow thickness and Clark level were found to be related to specific and disease-free survival. Breslow thickness greater than 4 mm was associated with greater risk of recurrence, and amelanosis and age of 60 and older were significantly associated with greater risk of death. Comparison of survival of patients with AM with that of those with NAM clearly showed that disease-free survival and overall survival were significantly lower in the former.
Survival differences between patients with AM and NAM are due to differences in already known prognostic factors, probably as a consequence of a delay in the diagnosis in these locations.
尽管肢端雀斑样痣黑色素瘤是肢端部位最常见的恶性黑色素瘤亚型,但肢端黑色素瘤(AM)这一术语必须与组织病理学描述相区分。
描述原发性AM患者的临床和病理特征,并阐明AM患者的预后是否与其他部位黑色素瘤(非肢端黑色素瘤;NAM)患者不同。
在20年期间,数据库中记录了连续822例黑色素瘤患者。从黑色素瘤登记处检索临床和随访数据并进行前瞻性分析。
89例患者的恶性黑色素瘤位于四肢的肢端部位。发现Breslow厚度和Clark分级与特定生存率和无病生存率相关。Breslow厚度大于4mm与复发风险增加相关,无色素沉着和60岁及以上年龄与死亡风险增加显著相关。AM患者与NAM患者生存率的比较清楚地表明,前者的无病生存率和总生存率显著较低。
AM患者与NAM患者之间的生存差异归因于已知预后因素的差异,可能是由于这些部位诊断延迟所致。